OPTIMIZER
Device
Impulse Dynamics (USA) Inc.
Total Payments
$8.1M
Transactions
15,559
Doctors
6,042
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $2.7M | 1,261 | 0 |
| 2023 | $3.9M | 13,567 | 5,972 |
| 2022 | $832,739 | 509 | 128 |
| 2021 | $670,651 | 194 | 9 |
| 2020 | $4,413 | 3 | 3 |
| 2019 | $6,865 | 5 | 1 |
| 2018 | $21,659 | 6 | 2 |
| 2017 | $1,892 | 14 | 8 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.2M | 2,551 | 76.4% |
| Food and Beverage | $634,535 | 12,456 | 7.8% |
| Honoraria | $544,970 | 247 | 6.7% |
| Consulting Fee | $520,483 | 73 | 6.4% |
| Travel and Lodging | $100,972 | 203 | 1.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $68,461 | 13 | 0.8% |
| Space rental or facility fees (teaching hospital only) | $52,000 | 16 | 0.6% |
Payments by Type
Research
$6.2M
2,551 transactions
General
$1.9M
13,008 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy | Impulse Dynamics (USA) Inc. | $3.6M | 0 |
| Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) | Impulse Dynamics (USA) Inc. | $2.5M | 0 |
| Arrythmia Burden in Cardiac Contractility Modulation (CCM) (ABC) | Impulse Dynamics (USA) Inc. | $62,335 | 0 |
| AIM HIGHer Study | Impulse Dynamics (USA) Inc. | $30,571 | 0 |
Top Doctors Receiving Payments for OPTIMIZER — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Cardiovascular Disease | Las Vegas, NV | $1,010 | 8 |
| , NP | Acute Care | Littleton, CO | $1,004 | 11 |
| , MD | Clinical Cardiac Electrophysiology | Dallas, TX | $1,000 | 1 |
| , NP-C | Nurse Practitioner | Hackensack, NJ | $1,000 | 1 |
| , PA-C | Medical | Williamsville, NY | $975.79 | 9 |
| Jessica Griffiths | Student in an Organized Health Care Education/Training Program | Greenville, SC | $936.97 | 14 |
| , M.D., PH.D | Cardiovascular Disease | Greenville, SC | $935.58 | 12 |
| , MD | Cardiovascular Disease | Paoli, PA | $931.87 | 12 |
| , M.D | Cardiovascular Disease | Houston, TX | $928.88 | 29 |
| , M.D | Cardiovascular Disease | Champaign, IL | $901.81 | 9 |
| , MD | Cardiovascular Disease | Houston, TX | $874.38 | 18 |
| , M.D | Specialist | St George, UT | $845.49 | 10 |
| , M.D | Cardiovascular Disease | Philadelphia, PA | $836.92 | 12 |
| , DO | Cardiovascular Disease | Philadelphia, PA | $831.15 | 5 |
| , M.D | Interventional Cardiology | El Paso, TX | $818.64 | 11 |
| , MD | Cardiovascular Disease | Saint Louis, MO | $805.78 | 18 |
| , MD | Family Medicine | Cheektowaga, NY | $799.67 | 9 |
| , D.O | Cardiovascular Disease | Greenwood Village, CO | $799.34 | 7 |
| , M.D | Clinical Cardiac Electrophysiology | Phoenix, AZ | $798.58 | 15 |
| , M.D | Student in an Organized Health Care Education/Training Program | Mesa, AZ | $782.44 | 7 |
| , MD | Cardiovascular Disease | Mcallen, TX | $778.72 | 7 |
| , CRNP | Adult Health | Phila, PA | $775.72 | 14 |
| , ACNP | Acute Care | Houston, TX | $767.47 | 8 |
| , M.D | Advanced Heart Failure and Transplant Cardiology | Robbinsville, NJ | $762.28 | 11 |
| , ANP-BC, RN | Nurse Practitioner | Houston, TX | $760.65 | 10 |
Ad
Manufacturing Companies
- Impulse Dynamics (USA) Inc. $8.1M
- Medtronic, Inc. $39,497
- Medtronic USA, Inc. $34,829
Product Information
- Type Device
- Total Payments $8.1M
- Total Doctors 6,042
- Transactions 15,559
About OPTIMIZER
OPTIMIZER is a device associated with $8.1M in payments to 6,042 healthcare providers, recorded across 15,559 transactions in the CMS Open Payments database. The primary manufacturer is Impulse Dynamics (USA) Inc..
Payment data is available from 2017 to 2024. In 2024, $2.7M was paid across 1,261 transactions to 0 doctors.
The most common payment nature for OPTIMIZER is "Unspecified" ($6.2M, 76.4% of total).
OPTIMIZER is associated with 4 research studies, including "Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy" ($3.6M).